Dolphin Medical Services Ltd
Incorporated in 1984, Dolphin Medical Services Ltd is in the business of diagnostics and
other allied services.[1]
- Market Cap ₹ 10.5 Cr.
- Current Price ₹ 6.98
- High / Low ₹ 9.57 / 1.98
- Stock P/E
- Book Value ₹ 8.45
- Dividend Yield 0.00 %
- ROCE -0.05 %
- ROE -0.39 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.83 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -32.5% over past five years.
- Promoter holding is low: 26.4%
- Company has a low return on equity of -3.73% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| 2.60 | 2.70 | 3.35 | 4.06 | 3.76 | 1.14 | 0.96 | 0.36 | 0.57 | |
| 2.07 | 2.14 | 2.24 | 2.82 | 2.83 | 1.73 | 1.06 | 0.39 | 0.39 | |
| Operating Profit | 0.53 | 0.56 | 1.11 | 1.24 | 0.93 | -0.59 | -0.10 | -0.03 | 0.18 |
| OPM % | 20.38% | 20.74% | 33.13% | 30.54% | 24.73% | -51.75% | -10.42% | -8.33% | 31.58% |
| 0.14 | 0.05 | 0.07 | 0.14 | -0.54 | -0.01 | 0.00 | 0.01 | 0.15 | |
| Interest | 0.11 | 0.02 | 0.54 | 0.67 | 1.19 | 0.70 | 0.05 | 0.05 | 0.06 |
| Depreciation | 0.31 | 0.39 | 0.57 | 0.59 | 0.65 | 0.65 | 0.71 | 0.52 | 0.34 |
| Profit before tax | 0.25 | 0.20 | 0.07 | 0.12 | -1.45 | -1.95 | -0.86 | -0.59 | -0.07 |
| Tax % | 44.00% | 35.00% | 228.57% | 100.00% | 2.76% | 1.54% | 0.00% | -3.39% | -28.57% |
| 0.14 | 0.13 | -0.09 | 0.00 | -1.49 | -1.98 | -0.86 | -0.57 | -0.05 | |
| EPS in Rs | 0.09 | 0.09 | -0.06 | 0.00 | -0.99 | -1.31 | -0.57 | -0.38 | -0.03 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -32% |
| 3 Years: | -21% |
| TTM: | 58% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 25% |
| TTM: | 91% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 19% |
| 3 Years: | 62% |
| 1 Year: | 210% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -6% |
| 3 Years: | -4% |
| Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 |
| Reserves | 2.57 | 2.70 | 2.61 | 2.61 | 1.12 | -0.86 | -1.72 | -2.30 | -2.34 |
| 0.17 | 5.49 | 6.94 | 6.99 | 7.69 | 8.24 | 8.10 | 8.05 | 8.16 | |
| 0.45 | 0.45 | 0.63 | 0.86 | 0.79 | 0.82 | 0.83 | 0.82 | 0.75 | |
| Total Liabilities | 18.29 | 23.74 | 25.28 | 25.56 | 24.70 | 23.30 | 22.31 | 21.67 | 21.67 |
| 7.47 | 8.50 | 12.14 | 15.69 | 11.40 | 11.94 | 11.23 | 14.69 | 14.34 | |
| CWIP | 0.00 | 8.14 | 6.64 | 3.28 | 7.29 | 6.10 | 6.11 | 2.14 | 2.14 |
| Investments | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| 10.41 | 6.69 | 6.09 | 6.18 | 5.60 | 4.85 | 4.56 | 4.43 | 4.78 | |
| Total Assets | 18.29 | 23.74 | 25.28 | 25.56 | 24.70 | 23.30 | 22.31 | 21.67 | 21.67 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| 2.00 | 1.36 | 0.00 | 1.30 | 0.15 | 0.19 | -0.12 | |||
| -9.57 | -3.23 | 0.00 | -0.50 | -0.12 | -0.17 | 0.01 | |||
| 5.19 | 1.37 | 0.00 | -0.88 | -0.03 | -0.02 | 0.11 | |||
| Net Cash Flow | -2.38 | -0.50 | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 | ||
| Free Cash Flow | -7.56 | -1.35 | 0.00 | 1.23 | 0.16 | 0.19 | -0.11 | ||
| CFO/OP | 357% | 123% | 0% | 140% | -25% | -190% | -67% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 13.86 | 21.22 | 45.62 | 36.50 | 36.50 | 21.47 | |||
| Days Payable | 13.86 | 4.24 | 0.00 | 12.17 | 73.00 | 0.00 | |||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.90 | 16.98 | 45.62 | 24.33 | -36.50 | 21.47 |
| Working Capital Days | 1,037.44 | 462.33 | 306.16 | 265.21 | 245.60 | 582.72 | 589.32 | 1,449.86 | 1,171.84 |
| ROCE % | 1.07% | 2.54% | 3.20% | 1.15% | -5.33% | -3.67% | -2.54% | -0.05% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Shares in Dematerialized Form % of share capital ・Standalone data |
|
||||||||
| Total Number of Shareholders count ・Standalone data |
|||||||||
| Promoter Holding % of share capital ・Standalone data |
|||||||||
| Number of Promoter Shareholders count ・Standalone data |
|||||||||
Extracted by Screener AI
Documents
Announcements
- Results: Unaudited Financial Results For The Quarter Ended June 30, 2026
-
Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026
- Q1 FY2027 results: revenue Rs 21.52 lakh, net profit Rs 1.78 lakh, approved on 14 Aug 2026.
-
Board Meeting Intimation for BM Intimation For BM Is Scheduled To Be Held On Thursday, August 14, 2026, Inter Alia, To Consider & Approve The Unaudited Standalone Financial Results Of The Company For The 1St Quarter Ended June 30, 2026 Of The Financial Year 2026-27
- Board meets August 14, 2026 to approve Q1 FY27 unaudited standalone results; trading window closed till 48 hours after results.
-
Updates on Open Offer
- Open offer for 39,25,988 shares at ₹4.80; tendering July 31–Aug 13, 2026.
-
Recommendations of the Committee of Independent Directors (''IDC'')
- Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors (''IDC'') of …
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
Business Overview:[1]
a) DMSL provides a range of tests covering Radiology and Imaging, Biochemistry, Pathology, and Microbiology, etc., to the people of the coastal region of Andhra Pradesh.
b) Additionally, it has the eye care
division called the Dolphin Nethralaya
which is a comprehensive eye care
and a laser and research centre.
c) The company has also ventured
into IT and Biotechnology and Herbal
sectors